Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Chierigo

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Urologic Oncology|July 11, 2022
Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy coreBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Seminars in Oncology|May 24, 2022
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumabRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
The Prostate|April 2, 2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidatesGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
The Prostate|March 15, 2023
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
International Urology and Nephrology|July 15, 2022
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
International Urology and Nephrology|November 19, 2021
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostateFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Clinical Genitourinary Cancer|May 26, 2022
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer PatientsFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
The Prostate|September 15, 2021
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
Frontiers in Oncology|December 10, 2021
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer PatientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
The Prostate|February 28, 2022
Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancerFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Urologic Oncology|July 11, 2022
Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy coreBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Seminars in Oncology|May 24, 2022
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumabRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
The Prostate|April 2, 2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidatesGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
The Prostate|March 15, 2023
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
International Urology and Nephrology|July 15, 2022
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
International Urology and Nephrology|November 19, 2021
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostateFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Clinical Genitourinary Cancer|May 26, 2022
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer PatientsFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
The Prostate|September 15, 2021
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
Frontiers in Oncology|December 10, 2021
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer PatientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
The Prostate|February 28, 2022
Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancerFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Pageof 11